Browse by author
Lookup NU author(s): Dr Laura Lane, Dr Claire WoodORCiD, Professor Timothy Cheetham
This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ. Graves' disease is a rare disorder that continues to present clinicians and families with a series of challenges. There are no new established treatments for children or adolescents, but the outcomes of recent clinical trials and meta-analyses have helped clinicians to prepare families for the road ahead. We have a more refined understanding of how to administer antithyroid drugs, which one to use and how long to treat the young person. We also have a greater insight into how best to reduce any risks associated with surgery and radioiodine. We understand more about long-term outcomes and their determinants and have greater awareness about the impact of the disease and its treatment on quality of life. A holistic approach to management is key to supporting and counselling young people and their families about the diagnosis and management options. In this review, we will discuss the recent literature and reflect on how this should be translated into clinical practice.
Author(s): Lane LC, Wood CL, Cheetham T
Publication type: Review
Publication status: Published
Journal: Archives of Disease in Childhood
Year: 2023
Volume: 108
Issue: 4
Pages: 276-281
Print publication date: 01/04/2023
Online publication date: 13/07/2022
Acceptance date: 27/06/2022
ISSN (print): 0003-9888
ISSN (electronic): 1468-2044
Publisher: BMJ Publishing Group
URL: https://doi.org/10.1136/archdischild-2022-323905
DOI: 10.1136/archdischild-2022-323905
PubMed id: 35831126
